Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Chromosoma|August 1, 1989
A group of non-Y encoded Drosophila hydei primary spermatocyte nuclear glycoproteins exhibits epitopes depending on formation of Y chromosomal giant lampbrush loopsG Tischendorf, W Liebrich, P Trapitz, et al.
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1982
Configuration assignments of the amino acid residues and the presence of N-methyldehydroalanine in toxins from the blue-green alga, Microcystis aeruginosaD P Botes, C C Viljoen, H Kruger, et al.
Cancer|October 1, 1990
Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine. First clinical results with tumor-cell vaccines modified with live but avirulent Newcastle disease virusW Bohle, P Schlag, W Liebrich, et al.
Langenbecks Archiv Fur Chirurgie|January 1, 1995
[Significance of serum beta-hCG as a tumor marker for stomach carcinoma]B Rau, C Below, W Haensch, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
In vitro and clinical characterisation of a Newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patientsW Liebrich, P Schlag, M Manasterski, et al.
Birth Defects Original Article Series|June 1, 1971
Congenital hair defectsA C Brown
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 21, 1987
Marine pollution and health in South AfricaA C Brown
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|November 9, 2000
Lupus erythematosus and nutrition: a review of the literatureA C Brown
Cancer|November 15, 1995
Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas. A reevaluationY Cao, U R Karsten, W Liebrich, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trialP Schlag, M Manasterski, T Gerneth, et al.
Pageof 12